Wellcome Trust launches investment wing


The Wellcome Trust has provided £200 million to launch an investment company that aims to support innovative healthcare businesses with the potential to transform the markets in which they operate.

The investment company, plans for which were revealed in March 2012, will operate as ‘Syncona’ and look to make investments in the £1–20 million range as a majority investor or as part of a syndicate.

Syncona chief executive Martin Murphy said: ‘We expect to play our part in building successful businesses based upon innovation within the life science and healthcare industry. We very much look forward to working with entrepreneurs, leading academics and inventors to build success stories in the UK, Europe and beyond.’

The Wellcome Trust is one of the largest charitable foundations in the world, spending £600 million per year to support biomedical research and the medical humanities.


Related Content

Wellcome Trust to enforce open access rules

28 June 2012 News and Analysis

news image

UK charitable foundation will cut the grants of scientists who do not make their research freely available

Wellcome Trust announces new head

1 May 2013 News and Analysis

news image

Jeremy Farrar to join the organisation on 1 October

Most Read

Not all science is created equal

16 October 2014 Comments

news image

John Ioannidis explains why researchers should be curious about the differences between disciplines

MDMA

9 October 2014 Podcast | Compounds

news image

The drug that fuelled rave culture may yet be a treatment for PTSD. Hayley Simon introduces MDMA

Most Commented

Cannabis chemists look for professional recognition

16 October 2014 News and Analysis

news image

The American Chemical Society is being petitioned to form a division to help develop standards in the field

Not all science is created equal

16 October 2014 Comments

news image

John Ioannidis explains why researchers should be curious about the differences between disciplines